Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Recurrent erythema multiforme major in an 8-year-old patient with recurrence of herpetic gingivostomatitis and HLA-B*5801 haplotype: A causal or casual relationship?

Grassi S, Bossi G, Croci GA, Brazzelli V.

JAAD Case Rep. 2019 Jul 12;5(7):617-620. doi: 10.1016/j.jdcr.2019.05.013. eCollection 2019 Jul. No abstract available.

2.

Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.

Michelerio A, Grassi S, Elena C, Croci GA, Boveri E, Bossi G, Brazzelli V.

Eur J Dermatol. 2019 Apr 1;29(2):174-178. doi: 10.1684/ejd.2019.3532.

PMID:
30973331
3.

Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome.

Montin D, Marolda A, Licciardi F, Robasto F, Di Cesare S, Ricotti E, Ferro F, Scaioli G, Giancotta C, Amodio D, Conti F, Giardino G, Leonardi L, Ricci S, Volpi S, Baselli LA, Azzari C, Bossi G, Consolini R, Dellepiane RM, Duse M, Gattorno M, Martire B, Putti MC, Soresina A, Plebani A, Ramenghi U, Martino S, Pignata C, Cancrini C.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2369-2376. doi: 10.1016/j.jaip.2019.03.014. Epub 2019 Mar 26.

PMID:
30922987
4.

Cytokine Modulation in Breast Cancer Patients Undergoing Radiotherapy: A Revision of the Most Recent Studies.

Marconi R, Serafini A, Giovanetti A, Bartoleschi C, Pardini MC, Bossi G, Strigari L.

Int J Mol Sci. 2019 Jan 17;20(2). pii: E382. doi: 10.3390/ijms20020382. Review.

5.

Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells.

Loria R, Giliberti C, Bedini A, Palomba R, Caracciolo G, Ceci P, Falvo E, Marconi R, Falcioni R, Bossi G, Strigari L.

J Exp Clin Cancer Res. 2019 Jan 3;38(1):1. doi: 10.1186/s13046-018-1018-6.

6.

Modelling the dynamics of a large rock landslide in the Dolomites (eastern Italian Alps) using multi-temporal DEMs.

Gatter R, Cavalli M, Crema S, Bossi G.

PeerJ. 2018 Nov 8;6:e5903. doi: 10.7717/peerj.5903. eCollection 2018.

7.

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules.

Harper J, Adams KJ, Bossi G, Wright DE, Stacey AR, Bedke N, Martinez-Hague R, Blat D, Humbert L, Buchanan H, Le Provost GS, Donnellan Z, Carreira RJ, Paston SJ, Weigand LU, Canestraro M, Sanderson JP, Botta Gordon-Smith S, Lowe KL, Rygiel KA, Powlesland AS, Vuidepot A, Hassan NJ, Cameron BJ, Jakobsen BK, Dukes J.

PLoS One. 2018 Oct 15;13(10):e0205491. doi: 10.1371/journal.pone.0205491. eCollection 2018.

8.

The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.

Merante S, Ferretti VV, Elena C, Brazzelli V, Zanotti R, Neri I, Magliacane D, Belloni Fortina A, Ingeborg F, Pastorello EA, Pieri L, Papayannidis C, Mauro M, Grifoni F, Minelli R, Guggiari E, Difonzo E, Bocchia M, Caroppo F, Di Nuzzo S, Elli EM, Rondoni M, Ciccocioppo R, Di Stefano M, Bossi G, Boveri E, Bonadonna P, Giona F, Valent P, Triggiani M.

Future Oncol. 2018 Nov;14(26):2713-2723. doi: 10.2217/fon-2018-0291. Epub 2018 Sep 12.

PMID:
30207489
9.

Hands-On Experience of Crowdsourcing for Flood Risks. An Android Mobile Application Tested in Frederikssund, Denmark.

Frigerio S, Schenato L, Bossi G, Mantovani M, Marcato G, Pasuto A.

Int J Environ Res Public Health. 2018 Sep 4;15(9). pii: E1926. doi: 10.3390/ijerph15091926.

10.

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D'Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A.

Ital J Pediatr. 2018 Aug 30;44(1):102. doi: 10.1186/s13052-018-0536-3. Review.

11.

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks.

Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, Bossi G, Buonuomo S, Cardinale F, Cortis E, De Benedetti F, De Zorzi A, Duse M, Del Principe D, Dellepiane RM, D'Isanto L, El Hachem M, Esposito S, Falcini F, Giordano U, Maggio MC, Mannarino S, Marseglia G, Martino S, Marucci G, Massaro R, Pescosolido C, Pietraforte D, Pietrogrande MC, Salice P, Secinaro A, Straface E, Villani A.

Ital J Pediatr. 2018 Aug 30;44(1):103. doi: 10.1186/s13052-018-0529-2. Review.

12.

Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer.

Stramucci L, Pranteda A, Bossi G.

Cancers (Basel). 2018 May 3;10(5). pii: E131. doi: 10.3390/cancers10050131. Review.

13.

Pediatric Old World cutaneous leishmaniasis treated with oral fluconazole: A case series.

Michelerio A, Barruscotti S, Bossi G, Brazzelli V.

Pediatr Dermatol. 2018 May;35(3):384-387. doi: 10.1111/pde.13493. Epub 2018 Mar 26.

PMID:
29582455
14.

Risk factors associated with complications/sequelae of acute and subacute haematogenous osteomyelitis: an Italian multicenter study.

Chiappini E, Krzysztofiak A, Bozzola E, Gabiano C, Esposito S, Lo Vecchio A, Govoni MR, Vallongo C, Dodi I, Castagnola E, Rossi N, Valentini P, Cardinale F, Salvini F, Bona G, Bossi G, Olivieri AN, Russo F, Fossali E, Bottone G, Dellepiane M, De Martino M, Villani A, Galli L.

Expert Rev Anti Infect Ther. 2018 Apr;16(4):351-358. doi: 10.1080/14787210.2018.1453357. Epub 2018 Mar 29.

PMID:
29569505
15.

Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis.

Mele D, Bossi G, Maggiore G, Oliviero B, Mantovani S, Bonelli B, Mondelli MU, Varchetta S.

Clin Immunol. 2018 Mar;188:31-37. doi: 10.1016/j.clim.2017.12.004. Epub 2017 Dec 9.

PMID:
29233784
16.

An immune-molecular hypothesis supporting infectious aetiopathogenesis of Kawasaki disease in children.

Capittini C, Emmi G, Mannarino S, Bossi G, Dellepiane RM, Salice P, Pietrogrande MC, Pasi A, De Silvestri A, Tinelli C, Martinetti M.

Eur J Immunol. 2018 Mar;48(3):543-545. doi: 10.1002/eji.201747226. Epub 2018 Jan 15.

17.

Atypical clinical presentation and successful treatment with oral cholic acid of a child with defective bile acid synthesis due to a novel mutation in the HSD3B7 gene.

Bossi G, Giordano G, Rispoli GA, Maggiore G, Naturale M, Marchetti D, Iascone M.

Pediatr Rep. 2017 Oct 10;9(3):7266. doi: 10.4081/pr.2017.7266. eCollection 2017 Oct 6.

18.

Polyfunctional response by ImmTAC (IMCgp100) redirected CD8+ and CD4+ T cells.

Boudousquie C, Bossi G, Hurst JM, Rygiel KA, Jakobsen BK, Hassan NJ.

Immunology. 2017 Nov;152(3):425-438. doi: 10.1111/imm.12779. Epub 2017 Aug 2.

19.

A meta-analysis of the abscopal effect in preclinical models: Is the biologically effective dose a relevant physical trigger?

Marconi R, Strolin S, Bossi G, Strigari L.

PLoS One. 2017 Feb 21;12(2):e0171559. doi: 10.1371/journal.pone.0171559. eCollection 2017.

20.

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.

Yang H, Buisson S, Bossi G, Wallace Z, Hancock G, So C, Ashfield R, Vuidepot A, Mahon T, Molloy P, Oates J, Paston SJ, Aleksic M, Hassan NJ, Jakobsen BK, Dorrell L.

Mol Ther. 2016 Nov;24(11):1913-1925. doi: 10.1038/mt.2016.114. Epub 2016 Jun 6.

21.

Narrow-band UVB phototherapy and psoralen-ultraviolet A photochemotherapy in the treatment of cutaneous mastocytosis: a study in 20 patients.

Brazzelli V, Grassi S, Merante S, Grasso V, Ciccocioppo R, Bossi G, Borroni G.

Photodermatol Photoimmunol Photomed. 2016 Sep;32(5-6):238-246. doi: 10.1111/phpp.12248. Epub 2016 Jul 27.

PMID:
27353865
22.

Pediatric Tuberculosis in Italian Children: Epidemiological and Clinical Data from the Italian Register of Pediatric Tuberculosis.

Galli L, Lancella L, Tersigni C, Venturini E, Chiappini E, Bergamini BM, Codifava M, Venturelli C, Tosetti G, Marabotto C, Cursi L, Boccuzzi E, Garazzino S, Tovo PA, Pinon M, Le Serre D, Castiglioni L, Lo Vecchio A, Guarino A, Bruzzese E, Losurdo G, Castagnola E, Bossi G, Marseglia GL, Esposito S, Bosis S, Grandolfo R, Fiorito V, Valentini P, Buonsenso D, Domenici R, Montesanti M, Salvini FM, Riva E, Dodi I, Maschio F, Abbagnato L, Fiumana E, Fornabaio C, Ballista P, Portelli V, Bottone G, Palladino N, Valenzise M, Vecchi B, Di Gangi M, Lupi C, Villani A, de Martino M.

Int J Mol Sci. 2016 Jun 17;17(6). pii: E960. doi: 10.3390/ijms17060960.

23.

Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex.

Garibaldi F, Falcone E, Trisciuoglio D, Colombo T, Lisek K, Walerych D, Del Sal G, Paci P, Bossi G, Piaggio G, Gurtner A.

Oncogene. 2016 Jul 21;35(29):3760-70. doi: 10.1038/onc.2016.51. Epub 2016 Mar 21.

PMID:
26996669
24.

Failure to thrive as presentation in a patient with 22q11.2 microdeletion.

Bossi G, Gertosio C, Meazza C, Farello G, Bozzola M.

Ital J Pediatr. 2016 Feb 11;42:14. doi: 10.1186/s13052-016-0224-0.

25.

MKK3 as oncotarget.

Bossi G.

Aging (Albany NY). 2016 Jan;8(1):1-2. No abstract available.

26.

Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.

Raman MC, Rizkallah PJ, Simmons R, Donnellan Z, Dukes J, Bossi G, Le Provost GS, Todorov P, Baston E, Hickman E, Mahon T, Hassan N, Vuidepot A, Sami M, Cole DK, Jakobsen BK.

Sci Rep. 2016 Jan 13;6:18851. doi: 10.1038/srep18851.

27.

Mutant p53 and sIL-1Ra.

Bossi G.

Aging (Albany NY). 2015 Oct;7(10):742-3. No abstract available.

28.

Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility.

Bossi G, Mannarino S, Pietrogrande MC, Salice P, Dellepiane RM, Cremaschi AL, Corana G, Tozzo A, Capittini C, De Silvestri A, Tinelli C, Pasi A, Martinetti M.

Genes Immun. 2015 Oct;16(7):481-7. doi: 10.1038/gene.2015.34. Epub 2015 Sep 3.

PMID:
26335810
29.

The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells.

Garufi A, Ubertini V, Mancini F, D'Orazi V, Baldari S, Moretti F, Bossi G, D'Orazi G.

J Exp Clin Cancer Res. 2015 Aug 22;34:87. doi: 10.1186/s13046-015-0206-x.

30.

A Land-Use Perspective for Birdstrike Risk Assessment: The Attraction Risk Index.

Coccon F, Zucchetta M, Bossi G, Borrotti M, Torricelli P, Franzoi P.

PLoS One. 2015 Jun 26;10(6):e0128363. doi: 10.1371/journal.pone.0128363. eCollection 2015.

31.

HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity.

Valente D, Bossi G, Moncada A, Tornincasa M, Indelicato S, Piscuoglio S, Karamitopoulou ED, Bartolazzi A, Pierantoni GM, Fusco A, Soddu S, Rinaldo C.

Oncotarget. 2015 Apr 30;6(12):10320-34.

32.

Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy.

Desantis A, Bruno T, Catena V, De Nicola F, Goeman F, Iezzi S, Sorino C, Ponzoni M, Bossi G, Federico V, La Rosa F, Ricciardi MR, Lesma E, De Meo PD, Castrignanò T, Petrucci MT, Pisani F, Chesi M, Bergsagel PL, Floridi A, Tonon G, Passananti C, Blandino G, Fanciulli M.

EMBO J. 2015 May 5;34(9):1214-30. doi: 10.15252/embj.201489920. Epub 2015 Mar 14.

33.

Abscopal effect of radiation therapy: interplay between radiation dose and p53 status.

Strigari L, Mancuso M, Ubertini V, Soriani A, Giardullo P, Benassi M, D'Alessio D, Leonardi S, Soddu S, Bossi G.

Int J Radiat Biol. 2015 Mar;91(3):294. doi: 10.3109/09553002.2014.997514. Epub 2015 Feb 4. No abstract available.

PMID:
25650895
34.

Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications.

Baldari S, Ubertini V, Garufi A, D'Orazi G, Bossi G.

Cell Death Dis. 2015 Jan 29;6:e1621. doi: 10.1038/cddis.2014.591.

35.

Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.

Ubertini V, Norelli G, D'Arcangelo D, Gurtner A, Cesareo E, Baldari S, Gentileschi MP, Piaggio G, Nisticò P, Soddu S, Facchiano A, Bossi G.

Oncogene. 2015 May 7;34(19):2493-504. doi: 10.1038/onc.2014.191. Epub 2014 Jul 7.

PMID:
24998848
36.

Degradation of mutant p53H175 protein by Zn(II) through autophagy.

Garufi A, Pucci D, D'Orazi V, Cirone M, Bossi G, Avantaggiati ML, D'Orazi G.

Cell Death Dis. 2014 May 29;5:e1271. doi: 10.1038/cddis.2014.217.

37.

Clinical features and follow-up in patients with 22q11.2 deletion syndrome.

Cancrini C, Puliafito P, Digilio MC, Soresina A, Martino S, Rondelli R, Consolini R, Ruga EM, Cardinale F, Finocchi A, Romiti ML, Martire B, Bacchetta R, Albano V, Carotti A, Specchia F, Montin D, Cirillo E, Cocchi G, Trizzino A, Bossi G, Milanesi O, Azzari C, Corsello G, Pignata C, Aiuti A, Pietrogrande MC, Marino B, Ugazio AG, Plebani A, Rossi P; Italian Network for Primary Immunodeficiencies.

J Pediatr. 2014 Jun;164(6):1475-80.e2. doi: 10.1016/j.jpeds.2014.01.056. Epub 2014 Mar 20.

PMID:
24657119
38.

ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells.

Bossi G, Buisson S, Oates J, Jakobsen BK, Hassan NJ.

Cancer Immunol Immunother. 2014 May;63(5):437-48. doi: 10.1007/s00262-014-1525-z. Epub 2014 Feb 15.

PMID:
24531387
39.

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells.

Bossi G, Gerry AB, Paston SJ, Sutton DH, Hassan NJ, Jakobsen BK.

Oncoimmunology. 2013 Nov 1;2(11):e26840. Epub 2013 Oct 21.

40.

Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status.

Strigari L, Mancuso M, Ubertini V, Soriani A, Giardullo P, Benassi M, D'Alessio D, Leonardi S, Soddu S, Bossi G.

Int J Radiat Biol. 2014 Mar;90(3):248-55. doi: 10.3109/09553002.2014.874608. Epub 2014 Feb 6. Erratum in: Int J Radiat Biol. 2015 Mar;91(3):294.

PMID:
24350918
41.

Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.

Cameron BJ, Gerry AB, Dukes J, Harper JV, Kannan V, Bianchi FC, Grand F, Brewer JE, Gupta M, Plesa G, Bossi G, Vuidepot A, Powlesland AS, Legg A, Adams KJ, Bennett AD, Pumphrey NJ, Williams DD, Binder-Scholl G, Kulikovskaya I, Levine BL, Riley JL, Varela-Rohena A, Stadtmauer EA, Rapoport AP, Linette GP, June CH, Hassan NJ, Kalos M, Jakobsen BK.

Sci Transl Med. 2013 Aug 7;5(197):197ra103. doi: 10.1126/scitranslmed.3006034.

42.

HLA class III genes involvement in Kawasaki disease: a case-control study in Caucasian population.

Maggioli E, Boiocchi C, Zorzetto M, Mannarino S, Bossi G, Cuccia M.

Int J Immunogenet. 2014 Feb;41(1):44-53. doi: 10.1111/iji.12077. Epub 2013 Jul 22.

PMID:
23870089
43.

Is there a role for the detection of autoantibodies in the clinical practice of treating infants with bullous pemphigoid? A case report.

Brazzelli V, Grasso V, Bossi G, Borroni G.

Pediatr Dermatol. 2014 Nov-Dec;31(6):748-9. doi: 10.1111/pde.12082. Epub 2013 Feb 14.

PMID:
23406459
44.

Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells.

Folgiero V, Di Carlo SE, Bon G, Spugnini EP, Di Benedetto A, Germoni S, Pia Gentileschi M, Accardo A, Milella M, Morelli G, Bossi G, Mottolese M, Falcioni R.

Cell Death Dis. 2012 Dec 6;3:e440. doi: 10.1038/cddis.2012.179.

45.

Cytogenetic analysis of human cells reveals specific patterns of DNA damage in replicative and oncogene-induced senescence.

Falcone G, Mazzola A, Michelini F, Bossi G, Censi F, Biferi MG, Minghetti L, Floridia G, Federico M, Musio A, Crescenzi M.

Aging Cell. 2013 Apr;12(2):312-5. doi: 10.1111/acel.12034. Epub 2012 Dec 25.

46.

Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy.

Catalano S, Panza S, Malivindi R, Giordano C, Barone I, Bossi G, Lanzino M, Sirianni R, Mauro L, Sisci D, Bonofiglio D, Andò S.

Int J Cancer. 2013 May 15;132(10):2237-47. doi: 10.1002/ijc.27915. Epub 2012 Nov 7.

47.

HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.

MacLeod SH, Elgadi MM, Bossi G, Sankar U, Pisio A, Agopsowicz K, Sharon D, Graham FL, Hitt MM.

Cancer Gene Ther. 2012 Dec;19(12):888-98. doi: 10.1038/cgt.2012.79. Epub 2012 Oct 26.

PMID:
23099884
48.

Monoclonal TCR-redirected tumor cell killing.

Liddy N, Bossi G, Adams KJ, Lissina A, Mahon TM, Hassan NJ, Gavarret J, Bianchi FC, Pumphrey NJ, Ladell K, Gostick E, Sewell AK, Lissin NM, Harwood NE, Molloy PE, Li Y, Cameron BJ, Sami M, Baston EE, Todorov PT, Paston SJ, Dennis RE, Harper JV, Dunn SM, Ashfield R, Johnson A, McGrath Y, Plesa G, June CH, Kalos M, Price DA, Vuidepot A, Williams DD, Sutton DH, Jakobsen BK.

Nat Med. 2012 Jun;18(6):980-7. doi: 10.1038/nm.2764.

PMID:
22561687
49.

Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals.

Goeman F, Manni I, Artuso S, Ramachandran B, Toietta G, Bossi G, Rando G, Cencioni C, Germoni S, Straino S, Capogrossi MC, Bacchetti S, Maggi A, Sacchi A, Ciana P, Piaggio G.

Mol Biol Cell. 2012 Apr;23(8):1467-74. doi: 10.1091/mbc.E12-01-0039. Epub 2012 Feb 29.

50.

PKC theta ablation improves healing in a mouse model of muscular dystrophy.

Madaro L, Pelle A, Nicoletti C, Crupi A, Marrocco V, Bossi G, Soddu S, Bouché M.

PLoS One. 2012;7(2):e31515. doi: 10.1371/journal.pone.0031515. Epub 2012 Feb 14.

Supplemental Content

Support Center